Last reviewed · How we verify

B12019 and Neulasta

Cinfa Biotech · Phase 1 active Biologic Quality 0/100

B12019 and Neulasta is a Biologic drug developed by Cinfa Biotech. It is currently in Phase 1 development.

At a glance

Generic nameB12019 and Neulasta
SponsorCinfa Biotech
ModalityBiologic
PhasePhase 1

Approved indications

No approved indications tracked.

Common side effects

No common side effects on file.

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

Frequently asked questions about B12019 and Neulasta

What is B12019 and Neulasta?

B12019 and Neulasta is a Biologic drug developed by Cinfa Biotech.

Who makes B12019 and Neulasta?

B12019 and Neulasta is developed by Cinfa Biotech (see full Cinfa Biotech pipeline at /company/cinfa-biotech).

What development phase is B12019 and Neulasta in?

B12019 and Neulasta is in Phase 1.

Related